Versarien Valuation

Is 9RV undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 9RV when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 9RV's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 9RV's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 9RV?

Key metric: As 9RV is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 9RV. This is calculated by dividing 9RV's market cap by their current revenue.
What is 9RV's PS Ratio?
PS Ratio	0.2x
Sales	UK£5.32m
Market Cap	UK£1.17m

9RV key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.9x
Enterprise Value/EBITDA	-0.8x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does 9RV's PS Ratio compare to its peers?

The above table shows the PS ratio for 9RV vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	0.7x
BIG1 Bio-Gate	0.8x	16.3%	€6.3m
BNN BRAIN Biotech	1.3x	8.5%	€70.8m
NTG Nabaltec	0.6x	5.1%	€122.3m
2HRA H&R GmbH KGaA	0.1x	3.0%	€128.4m
9RV Versarien	0.2x	n/a	€1.2m

Price-To-Sales vs Peers: 9RV is good value based on its Price-To-Sales Ratio (0.2x) compared to the peer average (0.7x).

Price to Sales Ratio vs Industry

How does 9RV's PS Ratio compare vs other companies in the DE Chemicals Industry?

3 Companies	Price / Sales	Estimated Growth	Market Cap
2HRA H&R GmbH KGaA	0.1x	3.0%	US$134.54m
NSAK OTI Greentech	0.03x	n/a	US$599.30k
B7Y Byotrol	0.04x	n/a	US$246.97k

No more companies available in this PS range

3 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: 9RV is good value based on its Price-To-Sales Ratio (0.2x) compared to the European Chemicals industry average (1x).

Price to Sales Ratio vs Fair Ratio

What is 9RV's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

9RV PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.2x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 9RV's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Stanmore Resources

AU$2.8b

Engages in the exploration, development, production, and sale of metallurgical coal in Australia.

S0D

AU$1.88

0.5%

-16.8%

Tokuyama

JP¥197.6b

Produces and sells various chemical products in Japan.

TBT

JP¥16.70

5.0%

16.0%

Mitsubishi Chemical Group

JP¥1.2t

Provides performance products, chemicals, industrial gases, health care products, and other products in Japan and internationally.

M3C

JP¥5.27

2.9%

-8.1%